507 related articles for article (PubMed ID: 27914211)
41. Profiling of circulating microRNAs: from single biomarkers to re-wired networks.
Zampetaki A; Willeit P; Drozdov I; Kiechl S; Mayr M
Cardiovasc Res; 2012 Mar; 93(4):555-62. PubMed ID: 22028337
[TBL] [Abstract][Full Text] [Related]
42. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
43. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
[TBL] [Abstract][Full Text] [Related]
44. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis.
Wang WT; Zhao YN; Han BW; Hong SJ; Chen YQ
J Clin Endocrinol Metab; 2013 Jan; 98(1):281-9. PubMed ID: 23118427
[TBL] [Abstract][Full Text] [Related]
45. HDL and microRNA therapeutics in cardiovascular disease.
Michell DL; Vickers KC
Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
[TBL] [Abstract][Full Text] [Related]
46. miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure.
Cruz MS; da Silva AMG; de Souza KSC; Luchessi AD; Silbiger VN
Heart Fail Rev; 2020 Mar; 25(2):321-329. PubMed ID: 31254148
[TBL] [Abstract][Full Text] [Related]
47. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.
Watson CJ; Gupta SK; O'Connell E; Thum S; Glezeva N; Fendrich J; Gallagher J; Ledwidge M; Grote-Levi L; McDonald K; Thum T
Eur J Heart Fail; 2015 Apr; 17(4):405-15. PubMed ID: 25739750
[TBL] [Abstract][Full Text] [Related]
49. MicroRNAs as Potential Biomarkers in Coronary Artery Disease.
Bergami M; Fabin N; Cenko E; Bugiardini R; Manfrini O
Curr Top Med Chem; 2023; 23(6):454-469. PubMed ID: 36545717
[TBL] [Abstract][Full Text] [Related]
50. Circulating microRNAs: potential biomarkers for common malignancies.
Khoury S; Tran N
Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
[TBL] [Abstract][Full Text] [Related]
51. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
52. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
53. Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.
Kim SH; Weiß C; Hoffmann U; Borggrefe M; Akin I; Behnes M
Curr Pharm Biotechnol; 2017; 18(6):445-455. PubMed ID: 28571562
[TBL] [Abstract][Full Text] [Related]
54. Can circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings?
Keller A; Meese E
Wiley Interdiscip Rev RNA; 2016; 7(2):148-56. PubMed ID: 26670867
[TBL] [Abstract][Full Text] [Related]
55. Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.
Mirra P; Raciti GA; Nigro C; Fiory F; D'Esposito V; Formisano P; Beguinot F; Miele C
Epigenomics; 2015; 7(4):653-67. PubMed ID: 26111035
[TBL] [Abstract][Full Text] [Related]
56. Application of microRNAs in diagnosis and treatment of cardiovascular disease.
Wronska A; Kurkowska-Jastrzebska I; Santulli G
Acta Physiol (Oxf); 2015 Jan; 213(1):60-83. PubMed ID: 25362848
[TBL] [Abstract][Full Text] [Related]
57. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
Fichtlscherer S; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
[TBL] [Abstract][Full Text] [Related]
58. Prognostic role of miRNAs in coronary artery disease.
Papageorgiou N; Tousoulis D; Charakida M; Briasoulis A; Androulakis E; Tentolouris C; Siasos G; Stefanadis C
Curr Top Med Chem; 2013; 13(13):1540-7. PubMed ID: 23745806
[TBL] [Abstract][Full Text] [Related]
59. Circulating microRNAs: novel biomarkers for cardiovascular diseases.
Xu J; Zhao J; Evan G; Xiao C; Cheng Y; Xiao J
J Mol Med (Berl); 2012 Aug; 90(8):865-75. PubMed ID: 22159451
[TBL] [Abstract][Full Text] [Related]
60. Extracellular vesicle microRNA transfer in cardiovascular disease.
Das S; Halushka MK
Cardiovasc Pathol; 2015; 24(4):199-206. PubMed ID: 25958013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
